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Abstract: 
Dynamic changes in synaptic strength rely on de novo protein synthesis and protein 
degradation by the ubiquitin proteasome system (UPS). Disruption of either of these cellular 
processes will result in significant impairments in synaptic plasticity and memory formation. 
Mutations in several genes encoding regulators of mRNA translation and members of the 
UPS have been associated with an increased risk for the development of autism spectrum 
disorders (ASD). It is possible that these mutations result in a similar imbalance in protein 
homeostasis (proteostasis) at the synapse. This review will summarize recent work 
investigating the role of the UPS in synaptic plasticity at glutamatergic synapses, and propose 
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that dysfunctional proteostasis is a common consequence of several genetic mutations linked 
to ASD.  
 
Protein synthesis and degradation in ASD/ID 
Functioning neural circuits require synaptic connections capable of strengthening or 
weakening in response to activity. This plasticity, measured electrophysiologically as the 
long-term potentiation or depression of synaptic strength (LTP/D), is particularly important 
for experience dependent memory formation. It is well established that de novo protein 
synthesis plays a fundamental role in supporting LTP/D and that it is required for the creation 
of new memories. Given this important role in synaptic plasticity, it is perhaps not surprising 
that mutations in several genes that encode regulators of protein synthesis have been 
identified as risk factors for the development of autism spectrum disorders with 
accompanying intellectual disability (ASD/ID) (Table 1) (Kelleher & Bear 2008, Bhakar et 
al. 2012). These include mutations in the FMR1 and TSC1 or 2 genes, which respectively 
give rise to the neurodevelopmental disorders fragile X syndrome (FXS) and Tuberous 
Sclerosis Complex (TSC), as well as many regulators of the Ras-MAPK and mTOR 
translation control pathways (Krab et al. 2008, Kelleher & Bear 2008). Studies in animal 
models of these disorders reveal that protein synthesis downstream of group I metabotropic 
glutamate receptors (mGluR1/5) is commonly disrupted, leading to dysfunctional LTD 
(Auerbach et al. 2011, Osterweil et al. 2010, Barnes et al. 2015, Krab et al. 2008, Bateup et 
al. 2011, Dolen et al. 2007). Subsequent studies in multiple other mouse models of ASD/ID 
reveal a similar dysregulation of protein synthesis and LTD (Table 1). Importantly, 
normalizing mRNA translation corrects aberrant synaptic plasticity and several other 
pathological phenotypes in many of these mutant models. 
Interestingly, the changes in protein synthesis observed in many mouse models of 
ASD/ID do not appear to be accompanied by significant changes in protein expression. One 
explanation is that there is a compensatory change in the rate of protein degradation in order 
to prevent large shifts in the abundance of the synaptic proteome. If so, it may be that this in 
itself contributes to the neurological phenotypes seen in these mutant models. Indeed, the 
coordination between protein synthesis and breakdown of proteins by the ubiquitin 
proteasome system (UPS) is thought to play an important role in the regulation of synaptic 
function and plasticity (Hanus & Schuman 2013). Although the role of the UPS in 
neurodevelopmental disorders has received relatively little attention, one of the most 
commonly mutated genes linked to ASD/ID encodes the ubiquitin E3 ligase Ube3a (Kishino 
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et al. 1997). Moreover, mutations in over a dozen other UPS genes have been identified as 
risk factors for ASD/ID (Table 2). An intriguing possibility is that imbalance in the 
combined process of protein synthesis and breakdown (proteostasis) could be a common 
contributor to the development of ASD/ID (Figure 1).  
In this review, we will summarize work linking ubiquitination and proteasome 
activity to changes in synapse function. Our emphasis will be on studies investigating the role 
of the UPS in the plasticity of excitatory synapses that contribute to learning and memory. 
The links between UPS dysfunction, protein synthesis, and the development of ASD/ID will 
be discussed. 
  
UPS regulation by synaptic activity 
The process of protein degradation is essential for the function of all eukaryotic cells, 
including neurons. Pathologically misfolded proteins must be removed, short-lived proteins 
must be quickly degraded in response to activity, and more stable constituents must be turned 
over to maintain the infrastructure of the cell. The majority of cytosolic and nuclear proteins 
are degraded by the UPS, which is comprised of the 26S proteasome and the ubiquitin ligases 
that tag proteins for degradation (for extensive review see Weissman 2001, Schmidt & Finley 
2014). The proteasome consists of multi-subunit 19S regulatory particles, and a 20S catalytic 
core that hydrolyzes ATP in order to break down target proteins (Weissman 2001). For 
recognition by the proteasome, proteins destined for degradation must be tagged with a 
polyubiquitin chain. The covalent attachment of ubiquitin to the target protein involves three 
different enzymes: the E1 ligase that activates monoubiquitin, the E2 ligase that conjugates 
additional ubiquitin monomers to form a chain, and finally the E3 ligase that selectively 
conjugates the polyubiquitin chain to its target protein (Schmidt & Finley 2014, Suryadinata 
et al. 2014). It is the affinity of E3 ligases for select protein targets that determines the 
specificity of the UPS for only those proteins that require degradation. Interestingly, the 
addition of a single ubiquitin to a target protein, rather than a polyubiquitin chain, may serve 
as a tag for intracellular trafficking rather than degradation. Generally, proteins bound to 
lysine 48 (K48) chains are directly targeted for proteasomal degradation while a lysine 63 
(K63) chain or a single ubiquitin molecule may result in significant effects in subcellular 
localization or activity of proteins (Suryadinata et al. 2014).  
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In neurons, the UPS has been implicated in several fundamental processes including 
morphogenesis, dendritic spine structure, synaptic activity, and the regulation of synaptic 
strength (for excellent reviews of these topics see Bingol & Sheng 2011, Tai et al. 2010, 
Hegde 2010, Hamilton & Zito 2013). Several lines of evidence show that the proteasome is 
regulated by neuronal activity through alterations in four factors: subunit composition, 
proteolytic activity, location within the cell and interaction with other proteins. Pioneering 
studies in cultured neurons showed that manipulation of neuronal activity resulted in a 
dramatic change in the ubiquitination and degradation of the postsynaptic proteome (Ehlers 
2003). Subsequent work revealed that proteasomes can be translocated from dendritic shafts 
into postsynaptic dendritic spines within minutes upon KCl-induced depolarization, leading 
to overall increased local proteolysis (Bingol & Schuman 2006). More recent studies 
expressing a proteasome substrate GFPu in cultured hippocampal neurons demonstrated that 
proteasomal breakdown is directly related to network activity. Blockade of action potential 
firing with the sodium channel blocker tetrodotoxin (TTX) decreased the degradation rate of 
GFPu whereas increasing neuronal activity with the GABA-A receptor (GABA-AR) 
antagonist bicuculline lead to more degradation (Djakovic et al. 2009).  
The majority of studies focused on UPS activity in synaptic function have examined 
excitatory neurotransmission through the activation of ion channel linked NMDA-type 
glutamate receptors (NMDARs) and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
receptors (AMPARs) at the postsynaptic membrane. Experiments in cultured neurons show 
that agonist induced activation of NMDARs leads to disassembly of the 26S proteasome, 
resulting in decreased proteolytic activity and a dissociation of E3 ligases from the 
proteasome (Tai et al. 2010). In addition, it may be that the NMDAR acts to stabilize 
proteasomes at synapses in order to facilitate the trafficking of AMPARs. Proteomic 
examination of hippocampal neurons from mice lacking the NMDAR subunit GluN2B 
reveals a decrease in the abundance of several proteasome subunits in purified postsynaptic 
density fractions (Ferreira et al. 2015).  
NMDARs also regulate UPS function through the activation of the abundant 
postsynaptic protein α−Ca2+/calmodulin dependent kinase II (αCaMKII). Evidence from 
cultured neurons shows that Ca2+-dependent activation of αCaMKII through either NMDARs 
or L-type voltage-gated Ca2+ channel results in an increased association with proteasomes, 
and the recruitment of proteasomes into synapses (Djakovic et al. 2009). The stimulation of 
proteasome activity by αCaMKII involves phosphorylation of the regulatory subunit Rpt6, 
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which increases the catalytic activity of the 20S core (Bingol et al. 2010). Evidence showing 
that αCaMKII itself can be ubiquitinated suggests that its effects on the proteasome could be 
autoregulatory (Na et al. 2012), however the specific E3 ligases regulating this process 
remain unknown.  
 
UPS regulation of the postsynaptic proteome 
Several studies have shown that manipulation of the UPS has a significant impact on 
both the structure and function of the postsynaptic compartment. Recent studies using 2-
photon live imaging in organotypic hippocampal slice culture showed that pharmacological 
inhibition of the UPS dramatically reduces the rate of dendritic spine outgrowth (Hamilton et 
al. 2012). This regulation of spine outgrowth by the UPS was seen to rely on the interaction 
between GluN2B and αCaMKII. Although the UPS substrates involved in dynamic spine 
morphogenesis have not been extensively characterized, the ubiquitination of the actin 
regulatory protein spine-associated Rap GTP activating protein (SPAR) has been implicated 
in dendritic spine shrinkage and synapse weakening (Pak et al. 2001).  
The UPS regulates numerous proteins that have a direct impact on synaptic 
transmission. This includes major postsynaptic scaffolding proteins such as PSD95, GKAP 
and Shank, as well as major plasticity related proteins (PrPs) such as Arc/Arg3.1 and 
αCaMKII (Ehlers 2003). Additionally, NMDARs and AMPARs themselves are major UPS 
substrates, as are a number of other neurotransmitter receptors including mGluR1/5, 
inhibitory GABARs, Kainate receptors, Glycine receptors, nicotinic acetylcholine receptors, 
and dopamine receptors (Lin & Man 2013). A recent study performed a systematic analysis 
of the ubiquitome in the adult rat brain using a new monoclonal antibody to purify 
ubiquitinated peptides. By mass spectrometry analysis the authors identified a wide range of 
ubiquitination events on 45 key components of the presynaptic region and of the postsynaptic 
density including PSD-95, CaMKII and receptors for AMPA, NMDA, GABA, serotonin and 
acetylcholine. Interestingly, several UPS proteins were also found to be ubiquitinated, 
including E1, E2, E3 ligases, 10 DUBs and several proteasome subunits (Na et al. 2012). 
 Degradation of the NMDAR is mediated by ubiquitination of the obligatory GluN1 
subunit by the E3 ligase Fbxo2, which directs receptors to cytosolic proteasomes (Kato et al. 
2005). The GluN2B subunit of the NMDAR is also ubiquitinated by the E3 ligase mind bomb 
2 (Mib2) (Jurd et al. 2008). Both mGluR1a and mGluR5 can be ubiquitinated by the E3 
ligase seven in absentia homolog 1A (Siah1a) leading to proteasomal degradation (Moriyoshi 
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et al. 2004). The ubiquitination of mGluR1a may be regulated by synaptic plasticity, as it has 
been shown to require the association with the Homer3 scaffolding protein (Rezvani et al. 
2012).  
One of the most well described postsynaptic targets of the UPS is the AMPAR. A 
recent study showed that all four AMPAR subunits (GluA1-4) are rapidly ubiquitinated upon 
brief application of AMPA or bicuculline in cultured neurons (Widagdo et al. 2015). The 
increase in neuronal activity leads to ubiquitination of GluA1 by the E3 ligase Nedd4-1, 
which internalizes AMPARs and directs them to endosomes and lysosomes for degradation 
(Schwarz et al. 2010). This process can be counteracted by the de-ubiquitinase (DUB) USP8 
in response to NMDAR activation, which promotes AMPAR reinsertion into the postsynaptic 
membrane (Scudder et al. 2014). Recently, in vivo and in vitro studies demonstrated that the 
DUB USP46 also targets GluA1, regulating AMPAR surface expression, endocytosis, and 
the strength of synaptic transmission (Huo et al. 2015). During homeostatic plasticity, GluA1 
is also targeted by the E3 ligase Cdh1-APC and degraded by the proteasome, a process that 
involves signaling through ephrin receptor EphA4 (Fu et al. 2011). Altogether, these studies 
indicate that ubiquitination is an important regulatory signal for controlling AMPAR 
function. This may explain the observed importance of the UPS for maintaining LTP and 
LTD, both of which occur through changes in AMPAR trafficking. 
 
The role of the UPS in synaptic plasticity 
Early experiments performed in Aplysia revealed a critical role for the UPS in the 
long-term facilitation (LTF) of synaptic strength at sensory-motor synapses (Hegde et al. 
1997). This observation was supported by subsequent experiments in rat hippocampal CA1 
showing that the proteasome inhibitor MG132 blocks both the early protein synthesis-
independent phase of LTP (E-LTP), and the late phase LTP (L-LTP) that requires protein 
synthesis (Karpova et al. 2006). Later experiments revealed that application of the specific 
proteasome inhibitor lactacystin enhanced E-LTP but blocked L-LTP at hippocampal CA1 
synapses (Fonseca et al. 2006, Dong et al. 2008). The specific effect of proteasome inhibitors 
on L-LTP but not E-LTP suggested that the requirement for protein degradation was related 
to the requirement for new protein synthesis. Further studies proved this correct, showing that 
the augmentation of LTP by proteasome inhibitors is blocked by the presence of the protein 
synthesis inhibitor anisomycin. This indicated that proteasome inhibition increases the 
induction of LTP by stabilizing locally translated proteins in dendrites (Dong et al. 2008). 
Supporting this interpretation, a recent study linked the enhancement of E-LTP by 
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proteasome inhibition to increases in the levels of the translation initiation factors eIF4E and 
eF1A (Dong et al. 2014). This study further suggested proteasome inhibition might impair 
the consolidation of L-LTP due to an accumulation of Paip2 and 4E-BP2, two translational 
repressors (Dong et al. 2014). 
Another way in which the UPS may modulate LTP is in the regulation of brain-
derived neurotropic factor (BDNF). Recent work showed that application of BDNF induced a 
rapid and transient decrease in proteasome activity in hippocampal synaptoneurosome 
fractions, and that the proteasome activator IU1 blocked the enhancement of E-LTP by 
BDNF (Santos et al. 2015). Similar to previous studies, the authors show that proteasome 
inhibitors block the expression of L-LTP and the effect of BDNF upon LTP consolidation 
(Santos et al. 2015). These results support earlier findings, and underscore the conclusion that 
the combination of both the degradation and synthesis of proteins is required to support the 
long term strengthening of synapses. 
Besides the role of proteasome activity in LTP some studies reported direct 
modulation of E3 ligases and DUBs by synaptic activity. Upon AMPAR stimulation Nedd4-1 
is redistributed to dendritic spines in a persistent and rapid manner while NMDAR 
stimulation selectively activates USP8. Therefore, Nedd4-1 and USP8 are regulated at 
synapses to control synaptic strength in an opposite fashion, regulating AMPAR 
ubiquitination and function. Moreover, bicuculline-induced downscaling of AMPARs and 
synaptic strength is accompanied by an increase in Nedd4-1 and a decrease in USP8 protein 
levels, respectively showing that E3 ligases and DUBs can be modulated during Hebbian and 
homeostatic plasticity (Scudder et al. 2014). 
The induction of LTD at hippocampal CA1 synapses can be induced by either the 
weak stimulation of NMDARs or through stimulation of mGluR1/5, both of which elicit 
changes in synaptic efficacy through AMPAR endocytosis (Dudek & Bear 1992, Huber et al. 
2001). Although they can occur at the same set of synapses, a major distinction is that 
mGluR-LTD requires new protein synthesis whereas NMDAR-LTD does not (Huber et al. 
2000). Interestingly, the role of the UPS may also differentiate these forms of LTD. Multiple 
studies have shown that proteasome inhibitors reduce the AMPAR endocytosis and LTD 
downstream of NMDAR activation (Colledge et al. 2003, Citri et al. 2009, Patrick et al. 
2003, Bingol & Schuman 2004). The role of the UPS in mGluR-LTD, however, is not as 
clear. Initial studies showed that incubation of hippocampal slices with the proteasome 
inhibitors MG132 or lactacystin resulted in impairment of mGluR-LTD (Hou et al. 2006). 
The authors proposed that the UPS sensitivity of mGluR-LTD was due to a breakdown of the 
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translation repressor fragile X mental retardation protein (FMRP), the protein lost in FXS 
(Hou et al. 2006). Recent work identifies Cdh1-APC as the E3 ligase responsible for FMRP 
degradation, and shows that mice lacking this ligase exhibit impaired mGluR-LTD (Huang et 
al. 2015). Along the same lines, another recent study showed that mGluR-LTD requires the 
rapid degradation of Arc/Arg3.1, a process that is counterbalanced by the RNA binding 
protein Sam68 (Klein et al. 2015). Together, these results support the idea that the UPS is 
required for the induction of mGluR-LTD. 
In contrast to these results, other studies find that the UPS may be inhibitory for 
mGluR-LTD. A study directly comparing both forms of LTD showed that the proteasome 
inhibitors MG132 and lactacystin inhibit NMDAR-LTD but enhance mGluR-LTD. 
Additionally, application of UBEI-41/PYR-41, a novel cell-permeable compound that 
irreversibly inhibits the E1 activating enzyme, was shown to enhance both the AMPAR 
internalization and LTD induced by the mGluR1/5 agonist DHPG (Citri et al. 2009). Other 
work shows that application of proteasome inhibitors enhances the transition from early-to 
late-phase LTD (Li et al. 2015). The seemingly dual nature of the UPS in LTD may be due to 
the regulation of different target proteins: those that are ubiquitinated to facilitate the 
induction of LTD and those that are broken down to limit the extent of LTD. Further 
investigation into the identity of these target proteins may clarify the opposing results 
regarding the function of the UPS during long-term plasticity. 
  
Requirement of the UPS for learning and memory 
The key role of proteasomal degradation in the expression of long-term synaptic 
plasticity has led to investigation of the UPS in learning and memory. A variety of different 
behavioral paradigms have been used to study the impact of synaptic plasticity on learning 
and memory formation. Using these paradigms, it has been shown that new mRNA 
translation facilitates memory formation by stabilizing molecular and synaptic changes 
during both consolidation (after learning) and reconsolidation (after memory reactivation) 
(reviewed in Jarome & Helmstetter 2014). In order to determine the role of the UPS in these 
aspects of memory formation, initial studies tested the effects of lactacystin infused into the 
hippocampus directly after training on an inhibitory avoidance (IA) learning task. The results 
showed that lactacystin infusion resulted in a full retrograde amnesia, similar to what is seen 
with protein synthesis inhibitors. Concomitantly, IA training resulted in an increase in protein 
ubiquitination and UPS activity in the hippocampus. These findings were the first to indicate 
that the UPS is crucial for the establishment of long-term memory in rats (Lopez-Salon et al. 
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2001). Since then, it has been demonstrated that the inhibition of the proteasome in multiple 
brain regions results in impairments in memory consolidation (Jarome & Helmstetter 2014).  
The reconsolidation of memory is also sensitive to proteasome inhibition. Studies in 
the hippocampus showed that infusion of lactacystin blocked the extinction of fear 
conditioning and prevented the memory-impairing effect of the protein synthesis inhibitor 
anisomycin when given after retrieval, but did not affect memory formation when 
administered after training. Based on this, the authors proposed that the UPS is required for 
the destabilization of preexisting memories, allowing for modification by reconsolidation or 
extinction (Lee et al. 2008). However, this conflicts with more recent work showing that both 
consolidation and reconsolidation depend on protein synthesis and also on protein 
degradation by UPS (Figueiredo et al. 2015). 
Nevertheless, there is a clear relationship between the requirement for new protein 
synthesis and UPS function in the acquisition of memory. Indeed, the time at which memory 
retention is sensitive to proteasome inhibitors is the same 3-4 hour post-acquisition time 
window that is sensitive to protein synthesis inhibitors (Bourtchouladze et al. 1998, 
Figueiredo et al. 2015). One possibility is that the degradation of translation inhibitors is 
needed to promote protein-synthesis dependent plasticity (Bingol & Sheng 2011). It is also 
possible that the non-proteolytic function of the UPS is required. Supporting this notion, the 
monoubiquitination of the translation regulator cytoplasmic polyadenylation element binding 
protein 3 (CPEB3) was shown to be critical for the consolidation of hippocampus dependent 
memories (Pavlopoulos et al. 2011). Further work is needed to understand the precise 
mechanisms by which the UPS contributes to the formation of new memories, and the 
potential regulation of protein synthesis.  
  
UPS mutations in ASD/ID 
The impact of proteasome dysfunction on human cognition has been an active field of 
research with respect to neurodegenerative disorders such as Alzheimer’s, Parkinson’s and 
Huntington’s disease. In these disorders is it widely accepted that proteasomal dysfunction is, 
at least in part, responsible for the formation of protein inclusions in specific neuronal 
subtypes that ultimately will cause neurodegeneration (Dantuma & Bott 2014). However, 
very little is known about the role of the UPS in neurodevelopmental disorders.  
One notable exception to this is Angelman Syndrome (AS), a neurodevelopmental 
disorder caused by disruption of the E3 ligase Ube3a, which is characterized by ID, 
developmental delay, seizures, motor disruptions and an unusually positive demeanor 
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(LaSalle et al. 2015). While the majority of cases are due to specific loss of the maternal 
UBE3A allele, several studies have shown that mutations affecting the catalytic domain of 
Ube3a can also result in AS symptomology (Cooper et al. 2004, Kishino et al. 1997, 
Matsuura et al. 1997). Missense mutations targeting an inhibitory phosphorylation site on 
Ube3a have also been identified as risk factors for developing ASD/ID (Yi et al. 2015). 
Interestingly, the duplication or triplication of the chromosomal region 15q11-q13 in which 
the UBE3A gene resides is a major cytogeneic risk factor for ASD (LaSalle et al. 2015). 
While it is not clear that this is due directly to the increased level of Ube3a, transgenic mice 
engineered to express multiple copies of the Ube3a gene exhibit impaired social behavior and 
communication, and increased repetitive behaviors (Smith et al. 2011). Together, these 
studies strongly suggest that misregulation of Ube3a function is a causative factor in the 
development of ASD/ID.  
Studies of the Ube3am-/p+ mouse model reveal several neuropathological changes 
reminiscent of AS, including deficits in synaptic plasticity in several brain regions and 
significant impairments in learning and memory (Mabb et al. 2011).  Given the many 
neurological phenotypes associated with changes in Ube3a expression, one major task in the 
field has been to identify brain-derived targets as disease-relevant substrates (LaSalle et al. 
2015). The most studied Ube3a substrate is Arc/Arg3.1, a cytoskeleton-associated protein 
known to regulate trafficking of AMPARs to the membrane (Greer et al. 2010). Interesting 
new work from Kuhnle and colleagues proposes an alternate mechanism by which Ube3a 
regulates Arc expression in immortalized cell lines. In this study the authors suggest that 
Ube3a negatively regulates Arc expression at the transcription level, rather than at the 
posttranslational level. In fact, the use of the DHFR-ubiquitin fusion protein system 
confirmed that overexpression of E6AP did not significantly affect the ubiquitination status 
or the levels or Arc (Kuhnle et al. 2013). Although these results have yet to be verified in 
neuronal cells, this is an important study because it shows a new level of regulation of Arc 
expression by Ube3a. However, this would seem to conflict with a recent study demonstrated 
that reduction of Arc levels in the Ube3am-/p+ mouse model ameliorated some phenotypes 
presented by the model of Angelman Syndrome (Mandel-Brehm et al. 2015). More research 
into the regulation of Arc is certain to reveal the relationship between these results. Indeed, 
Arc degradation by the UPS is also regulated by Triad3A (Mabb et al. 2014) showing a 
complex mechanism of regulation of Arc protein levels. 
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Another interesting target of Ube3a is the mammalian target of rapamycin (mTOR) 
suppressor protein Tsc2 (Zheng et al. 2008). Recent work suggests that breakdown of Tsc2 
by Ube3a may contribute to pathology in the Ube3am-/p+ mouse of AS, as treatment with the 
mTOR inhibitor rapamycin rescued motor deficits and abnormal dendritic branching (Sun et 
al. 2015). Despite these results, it is important to consider that the Ube3a substrates described 
so far contribute to only a subset of phenotypes associated with AS. It may be that the key 
Ube3a substrates have not yet been identified or, more likely, that the disruption of Ube3A 
leads to a multiplicative effect involving multiple downstream targets. Indeed, recent in vitro 
studies reveal that Ube3a promotes the ubiquitination of the 26S proteasome itself, 
suggesting that it can have a significant impact on overall UPS function (Jacobson et al. 
2014).  
In addition to UBE3A, mutations in over a dozen other UPS genes, mainly E3 ligases, 
have been identified as ASD/ID risk factors (Table 2). Large-scale studies have identified 
copy number variations (CNVs) that result in the deletion of the E3 ligase gene PARK2, and 
duplication in the E3 ligase genes RFWD2 and FBXO40 (Glessner et al. 2009). A more 
recent study focused on rare de novo CNVs in ASD families from the Simons Simplex 
Collection identified a duplication of the DUB gene USP7 (Sanders et al. 2011). The function 
of these genes in brain development and synaptic plasticity remains to be clarified. However, 
mutation of the Uba6 gene encoding an E1 ubiquitin activating ligase has recently been 
shown to result in phenotypes reminiscent of ASD mouse models, including increased 
dendritic spine density, altered levels of Shank3 and Ube3a, and behavioral deficits including 
anxiety, reduced social interaction and impaired communication (Lee et al. 2013, Lee et al. 
2015). Additional studies should address the question of whether a phenotypes related to 
ASD/ID are common neurobiological consequences of UPS gene mutation. 
 
Problematic proteostasis in ASD/ID 
As large-scale genetic studies continue to identify novel mutations linked to ASD/ID, 
it is becoming more essential to understand the functional consequences of these mutations. 
Studies in mutant mouse models suggest that synaptic protein synthesis is dysregulated in 
several genetic causes of ASD/ID. Considering the clear functional connection between 
protein synthesis and breakdown, it is not unreasonable to suspect that changes in UPS 
function would result in similar pathology (Figure 1A). Evidence from the studies of UBE3A 
mutation illustrate that changes in UPS activity can lead to the multiple pathological changes 
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seen in ASD/ID. However, whether other UPS gene mutations lead to neuropathology 
reminiscent of ASD or ID remains to be determined.  
Another important question is whether disorders that arise due to disruption of protein 
synthesis also result in changes in UPS function. In this case, pathological changes would not 
be due to changes in protein levels per se, but rather an increase in protein turnover (Figure 
1B). This could impair synaptic function by increasing the ratio of new to old proteins, which 
could have a drastic impact on regulation and function. Alternatively, the compensatory 
change in the UPS could lead to aberrant breakdown of inappropriate target proteins, or 
altered ubiquitin-regulated trafficking of these targets. Teasing this apart would be of 
particular importance for guiding potential treatment strategies. Indeed, it is possible that the 
alterations in protein synthesis and compensatory changes in UPS function could contribute 
to different symptom domains of ASD/ID. Examination of the disruptions that occur in the 
collective process of proteostasis may therefore be an important next step in understanding 
the pathogenesis of ASD/ID. 
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GENE DISORDER FUNCTION PHENOTYPES REFERENCES 
FMR1 Fragile X 
syndrome (ID, 
ASD) 
Translation repressor Enhanced mGluR-LTD 
Impaired LTP 
Impaired learning and memory 
(reviewed in (Darnell & Klann 
2013, Bhakar et al. 2012) 
CYFIP1 ASD Translation repressor Enhanced mGluR-LTD 
Enhanced extinction of 
inhibitory avoidance 
(Bozdagi et al. 2012, Wang et 
al. 2015, Nishimura et al. 
2007) 
SYNGAP1 ID, ASD Ras-MAPK negative 
regulator 
Enhanced mGluR-LTD 
Impaired LTP 
Learning and memory deficits 
(Komiyama et al. 2002, 
Barnes et al. 2015, Jeyabalan 
& Clement 2016) 
NF1 Neurofibromatosis 
type 1 (ID) 
Ras-MAPK negative 
regulator 
Impaired LTP 
Abnormal spatial learning 
(Costa et al. 2002, Silva et al. 
1997, Sanders et al. 2011) 
 
TSC1/2 
 
Tuberous sclerosis 
complex (ID, 
ASD) 
Rheb-mTOR 
negative regulator 
Impaired mGluR-LTD 
Abnormal LTP 
Learning and memory deficits 
(Auerbach et al. 2011, 
Ehninger et al. 2008) 
PTEN Cowden syndrome 
(ID, ASD) 
PI3K-mTOR 
negative regulator 
Impaired LTP and LTD 
Impaired spatial memory 
(Butler et al. 2005, Kwon et 
al. 2006, Sperow et al. 2012) 
RPL10 ID, ASD Ribosomal protein ND (Klauck et al. 2006, Thevenon 
et al. 2015, Brooks et al. 
2014) 
RPS6KA2 ASD Ribosomal p90 S6 
kinase (MAPK 
pathway) 
ND (Marshall et al. 2008) 
RPS6KA3 ID, ASD Ribosomal p90 S6 
kinase (MAPK 
pathway) 
Impaired spatial learning (Matsumoto et al. 2013, 
O'Roak et al. 2012, Zeniou et 
al. 2002, Zeniou-Meyer et al. 
2010) 
EIF4E ASD Initiation factor Enhanced mGluR-LTD 
Impaired social behaviour 
Repetitive behaviours 
(Neves-Pereira et al. 2009, 
Kelleher et al. 2012, Gkogkas 
et al. 2013, Santini et al. 
2013) 
EEF1A2 ASD/ID Elongation factor ND (Nakajima et al. 2015, de Ligt 
et al. 2012) 
RBMS3 ASD RNA binding 
protein 
ND (O'Roak et al. 2011) 
HRAS Costello syndrome 
(ASD) 
Ras GTPase Enhanced LTP 
Enhanced spatial learning 
Enhanced fear conditioning 
(Herault et al. 1993, Comings 
et al. 1996, Herault et al. 
1995, Alfieri et al. 2015, 
Kelleher et al. 2012, Manabe 
et al. 2000, Kushner et al. 
2005) 
BRAF Costello 
syndrome/ Noonan 
syndrome (ID, 
ASD) 
MAPK activator Impaired LTP 
Impaired spatial learning 
Impaired contextual 
discrimination 
(Alfieri et al. 2014, Chen et 
al. 2006) 
PTPN11 Noonan syndrome 
(ID) 
Ras pathway 
regulator 
Impaired LTP 
Impaired spatial learning 
(Tartaglia et al. 2001, 
Deciphering Developmental 
Disorders 2015, Krumm et al. 
2015, Lee et al. 2014) 
SOS1 Noonan syndrome 
(ID) 
Ras pathway 
regulator 
ND (Tartaglia et al. 2007, Roberts 
et al. 2007) 
 
Table 1. ASD/ID mutations in genes encoding regulators of mRNA translation. Several 
genetic mutations that confer risk for developing ASD or ID are found in genes related to 
protein synthesis. These include regulators of the Ras-MAPK and mTOR signalling pathways 
that control mRNA translation at synapses. Synaptic plasticity and learning phenotypes are 
seen in mouse models of many of these disorders (ND = not determined). 
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GENE DISORDER FUNCTION PHENOTYPES REFERENCES 
UBE3A Angelman 
syndrome (ID, 
ASD), ASD 
E3 ubiquitin ligase Enhanced mGluR-LTD 
Impaired LTP 
Deficits in contextual learning 
(Jiang et al. 1998, Pignatelli et 
al. 2014) 
UBE3B ASD E3 ubiquitin ligase ND (Chahrour et al. 2012, Basel-
Vanagaite et al. 2012, Flex et 
al. 2013) 
UBE3C ASD E3 ubiquitin ligase ND (O'Roak et al. 2012) 
UBR7 ID E3 ubiquitin ligase ND (Najmabadi et al. 2011) 
PARK2 ASD E3 ubiquitin ligase ND (Glessner et al. 2009) 
FBXO40 ASD E3 ubiquitin ligase ND (Glessner et al. 2009) 
RFWD2 ASD E3 ubiquitin ligase ND (Glessner et al. 2009) 
Cullin 3 ASD E3 ubiquitin ligase ND (O'Roak et al. 2012, Codina-
Sola et al. 2015) 
Cullin 7 ASD E3 ubiquitin ligase ND (Krumm et al. 2015) 
HECW2 ASD E3 ubiquitin ligase ND (Krumm et al. 2015) 
HERC2 ASD E3 ubiquitin ligase ND (Harlalka et al. 2013, 
Puffenberger et al. 2012) 
HUWE1 ID, ASD E3 ubiquitin ligase ND (Froyen et al. 2008, Nava et 
al. 2012, Froyen et al. 2012, 
Vandewalle et al. 2013) 
UBL7 ASD Ubiquitin binding 
protein 
ND (Salyakina et al. 2011) 
PSMD10 ASD Proteasome protein ND (Piton et al. 2011) 
USP9Y ASD De-ubiquitinase ND ND 
USP45 ASD De-ubiquitinase ND ND 
USP7 ASD De-ubiquitinase ND ND 
 
Table 2. ASD/ID risk factors in ubiquitin proteasome system (UPS) genes. Mutations in 
several UPS genes have been identified as risk factors for ASD or ID. These include multiple 
genes encoding ubiquitin E3 ligases and de-ubiquitinases that regulate protein degradation. 
With the exception of mutations in UBE3A, the functional consequences of these gene 
mutations have not been determined (ND). 
 
 
Figure 1. Dysregulation of protein synthesis or degradation results in unbalanced 
proteostasis.  
(A) Mutations in several genes that regulate mRNA translation and ubiquitin proteasome 
system function have been implicated in ASD/ID (see Tables 1-2). This includes regulators 
of translation control signalling pathways (TSC1/2, NF1, PTEN, SYNGAP1, PTPN11, HRAS), 
protein synthesis regulators (FMR1, CYFIP1, EIF4E, RBMS3, RPL10, RPSS6KA2,3), E3 
ubiquitin ligases (UBE3A,B,C, CULLIN3,7, PARK2, FBXO40, RFWD2, HERC2, HECW2, 
HUWE1), de-ubiquitinases (USP7, USP45, USP9Y), and the proteasome protein PSMD10. 
The proteins encoded by these genes collectively contribute to the proteostasis involved in 
synaptic plasticity. (B) The pathogenic excess in synaptic protein synthesis observed in 
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animal models of ASD/ID (i.e., FMR1, SYNGAP1, and CYFIP1) may lead to a homeostatic 
increase in UPS function. Similarly, mutations in E3 ligases, such as Ube3A, that decrease 
UPS function may result in a compensatory decrease in protein synthesis. In both cases, the 
imbalance in proteostasis would lead to a change in the composition of new versus old 
plasticity related proteins (PrPs) in the synaptic proteome without necessarily affecting 
overall protein levels. 
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